Contents

Current Drug Targets, Volume 10 - Number 2

Editorial [Hot Topic: The Fabisch-Symposium 2009 on Targeted Tumor Therapies(Guest Editors: C. Bachran and H. Fuchs)]

, 10(2): 88

Christopher Bachran and Hendrik Fuchs


DOI: 10.2174/138945009787354548




Targeted Tumor Therapies at a Glance

, 10(2): 89 - 93

H. Fuchs and C. Bachran


DOI: 10.2174/138945009787354557




Targeted Cancer Immunotherapy Using Ligands of the Tumor Necrosis Factor Super-Family

, 10(2): 94 - 103

E. Bremer, M. de Bruyn, H. Wajant and W. Helfrich


DOI: 10.2174/138945009787354593




Anti-CD3 Recombinant Diphtheria Immunotoxin Therapy of Cutaneous T Cell Lymphoma

, 10(2): 104 - 109

A. E. Frankel, S. L. Zuckero, A. A. Mankin, M. Grable, K. Mitchell, Y. J. Lee, D. M. Neville and J. H. Woo


DOI: 10.2174/138945009787354539




Anti-CD30 Human IL-2 Fusion Proteins Display Strong and Specific Cytotoxicity In Vivo

, 10(2): 110 - 117

B. Hirsch, J. Brauer, M. Fischdick, C. Loddenkemper, S. Bulfone-Paus, H. Stein and H. Durkop


DOI: 10.2174/138945009787354566




Targeted Therapies for Prostate Cancer Against the Prostate Specific Membrane Antigen

, 10(2): 118 - 125

U. Elsasser-Beile, P. Buhler and P. Wolf


DOI: 10.2174/138945009787354601




Convection-Enhanced Delivery: Neurosurgical Issues

, 10(2): 126 - 130

W. A. Hall


DOI: 10.2174/138945009787354575




Reducing the Immunogenicity of Protein Therapeutics

, 10(2): 131 - 139

Masanori Onda


DOI: 10.2174/138945009787354511




Saponins as Tool for Improved Targeted Tumor Therapies

, 10(2): 140 - 151

H. Fuchs, D. Bachran, H. Panjideh, N. Schellmann, A. Weng, M. F. Melzig, M. Sutherland and C. Bachran


DOI: 10.2174/138945009787354584




Targeting: The ADEPT Story So Far

, 10(2): 152 - 157

K. D. Bagshawe


DOI: 10.2174/138945009787354520




Current Constructs and Targets in Clinical Development for Antibody- Based Cancer Therapy

, 10(2): 158 - 175

P. M. Deckert


DOI: 10.2174/138945009787354502




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science